Coherus Oncology (CHRS) Loans and Notes Receivables: 2013-2015
- Coherus Oncology's Loans and Notes Receivables was N/A to $1.8 million in Q1 2015 from the same period last year, while for Mar 2015 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2014, which is 1596.26% up from last year.
- According to the latest figures from Q1 2015, Coherus Oncology's Loans and Notes Receivables is $1.8 million, which was up 1.21% from $1.8 million recorded in Q4 2014.
- In the past 5 years, Coherus Oncology's Loans and Notes Receivables registered a high of $1.8 million during Q1 2015, and its lowest value of $107,000 during Q4 2013.
- Its 3-year average for Loans and Notes Receivables is $1.3 million, with a median of $1.8 million in 2014.
- Data for Coherus Oncology's Loans and Notes Receivables shows a peak YoY spiked of 1,596.26% (in 2014) over the last 5 years.
- Over the past 3 years, Coherus Oncology's Loans and Notes Receivables (Quarterly) stood at $107,000 in 2013, then surged by 1,596.26% to $1.8 million in 2014, then reached $1.8 million in 2015.
- Its Loans and Notes Receivables stands at $1.8 million for Q1 2015, versus $1.8 million for Q4 2014 and $107,000 for Q4 2013.
